20,000
Participants
Start Date
December 31, 2016
Primary Completion Date
July 31, 2025
Study Completion Date
July 31, 2025
Enteric Coated Aspirin
Warfarin
Rivaroxaban
New York University, New York
Northwell Health, New York
Penn State Hershey Med Center, Hershey
University of Pennsylvania, Philadelphia
Sinai Hospital, Baltimore
Johns Hopkins University, Baltimore
Anderson Orthopaedic Institute (VA), Alexandria
University of Virginia, Charlottesville
Virginia Commonwealth University Medical Center, Richmond
West Virginia University, Morgantown
Duke University Medical Center, Durham
Medical University of South Carolina, Charleston
Arthritis Surgery Research Foundation, South Miami
Cleveland Clinic, Cleveland
Indiana University, Indianapolis
Mayo Clinic, Rochester
Rush University Medical Center, Chicago
University of Nebraska Medical Center, Omaha
University of Arkansas for Medical Sciences, Little Rock
University of Utah, Salt Lake City
Mayo Clinic, Scottsdale
UCLA, Los Angeles
Stanford University Hospital, Stanford
University of Washington, Seattle
Brigham & Women's Hospital, Boston
Boston University Medical Center, Boston
Beth Israel Deaconess Medical Center, Boston
Lahey Clinic, Burlington
Dartmouth-Hitchcock Medical Center, Lebanon
Lifespan Health, East Providence
London Health Sciences Centre, London
University of Ottawa, Ottawa
Patient-Centered Outcomes Research Institute
OTHER
University of Maryland, Baltimore
OTHER
Brigham and Women's Hospital
OTHER
Northwestern University
OTHER
Medical University of South Carolina
OTHER
Dartmouth-Hitchcock Medical Center
OTHER